[1] Chen LP, Thomas EK, Hu SL, et al. Human papillomavirus type 16nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A, 1991, 88: 110-114. [2] Peng S, Frazer IH, Fernando GJ, et al. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class Ⅰ pathway. Virology, 1998, 240: 147-157. [3] Qi YM, Peng SW, Hengst K, et al. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein.Virology, 1996, 216: 35-45. [4] 程浩,郑树,周健.含人类乳头瘤病毒16E7-L1的嵌合型病毒样颗粒的构建、表达和纯化鉴定.中华皮肤科杂志,1999,32 : 226-229. [5] Muller M, Zhou J, Reed TD, et al. Chimeric papillomavirus-like particles. Virology, 1997, 234:93-111. [6] Paintsil J, Muller M, Picken M, et al. Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation. Virology, 1996, 223: 238-244. [7] 程浩,郑树,刘晓松,等.含HPV16E7的嵌合型VLPs引发细胞溶解反应.中华微生物学和免疫学杂志,2000,20:540-542. |